Therapeutically targeting oncogenic CRCs facilitates induced differentiation of NB by RA and the BET bromodomain inhibitor

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 01, 2021
Source ID
10.1016/j.omto.2021.09.004

Entities

People

  • Kevin W Freeman
  • Mellessa Miller
  • Nour A. Aljouda
  • Satyanarayana Alleboina

Organizations

  • National Institutes of Health
  • United States Department of Defense